EX-23.2 6 actuate_ex2302.htm CONSENT OF KMJ CORBIN & COMPANY LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statement No. 333-281557 on Form S-8 of our report dated February 29, 2024 (except for the retroactive effect of the 1-for-1.8 reverse stock split as described in the “Reverse Stock Split” section of Note 1, as to which the date is June 7, 2024, and except for Note 14, as to which the date is March 13, 2025), relating to the 2023 consolidated financial statements of Actuate Therapeutics, Inc. and subsidiary, appearing in this Annual Report on Form 10-K of Actuate Therapeutics, Inc. for the year ended December 31, 2024.

 

 

 

/s/ KMJ Corbin & Company LLP

 

Glendora, California
March 13, 2025